A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
A Validation Study of an AFP Whole Blood One-Step Rapid Home Detection Kit in Screening for HCC
2021
Medical & Clinical Research
Hepatocellular carcinoma (HCC) is still a main cause of cancer-related death in China. Early detection and diagnosis may increase the likelihood of curing the HCC. Dynamic monitoring AFP levels can be a surveillance indicator to detect early-stage HCC. However, to our disappointment, most people with chronic liver diseases do not test AFP levels regularly for a variety of reasons. The AFP whole blood one-step rapid home detection kit, with a high sensetivity and specifitivity, can be used to
doi:10.33140/mcr.06.05.07
fatcat:r5m6a7sdszelti2ne7dd3ib6ey